Tempus AI股价在获得心脏监测软件FDA许可后上涨

英为财情
Jul 16, 2025

Investing.com -- 精准医疗技术公司Tempus AI, Inc. (NASDAQ:TEM)周三股价上涨3%,此前该公司宣布其Tempus ECG-Low EF软件获得美国食品药品监督管理局(FDA)的510(k)许可。 这款由人工智能驱动的软件旨在识别可能存在低左心室射血分数(LVEF)的患者,LVEF衡量的是每次心跳时泵出的血液百分比。LVEF降低可能表明严重的心血管疾病,包括...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10